Thus, 10 of the 11 individuals in the placebo group had exacerbations that resulted in treatment with prednisone or antibiotics. In contrast, there were two events in the mepolizumab group . A transformation in the Likert level alone or physician discretion was not found in any patient to recognize an exacerbation or initiate a transformation in the dose of prednisone . The median period to exacerbation was 20 weeks in the mepolizumab group and 12 weeks in the placebo group .4 percent of the maximum possible reduction per process, as compared with 47.5 percent in the placebo group . In absolute terms, the mean dosage of prednisone was decreased from 11.9 to 3.9 mg in the mepolizumab group and from 10.7 to 6.4 mg in the placebo group . Prespecified Subgroup Analyses Data for 8 of 10 patients in the placebo group who all had an exacerbation accompanied by sputum eosinophilia were censored during exacerbation, whereas none of the sufferers in the mepolizumab group had an exacerbation connected with sputum eosinophilia .Catch the details on that tale at The UK Guardian newspaper is also reporting on soaring food prices because of fast-rising commodity costs: I also predicted meals disruptions in my set of predictions published earlier this year at Make no mistake: Food prices are on the rise. And with the Fed watering down the dollar thanks to its insane money counterfeiting policies, the U.S. Is normally headed into a cost inflation / dollar deflation scenario that mean you will need to spent a lot more dollars to buy the same meals in 2015 as you did in 2010 2010.